Skip to main content

What the FDA labels say about taking them together

Ticagrelor and voriconazole

Ticagrelor's FDA label of May 7, 2026 names voriconazole in its drug interactions section; the voriconazole labels PlainMeds reads (3) do not name ticagrelor. The ticagrelor label: “Avoid use of strong inhibitors of CYP3A.”

Check it at the source: the ticagrelor FDA label on DailyMed (effective May 7, 2026, AstraZeneca Pharmaceuticals LP); the voriconazole FDA label on DailyMed (effective February 26, 2026, Roerig).

What does the ticagrelor label say about voriconazole?

Ticagrelor label, drug interactions

Avoid use of strong inhibitors of CYP3A (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin) [see Clinical Pharmacology (12.3) ].

Source: FDA drug label (BRILINTA), AstraZeneca Pharmaceuticals LP, effective May 7, 2026 (SPL set f7b3f443-e83d-4bf2-0e96-023448fed9a8), via openFDA; the full label on DailyMed

What does the voriconazole label say about ticagrelor?

Voriconazole's label (effective February 26, 2026) and its 2 other brand-application labels do not name ticagrelor in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (VFEND), NDA021630 (Pf Prism Cv), as published by Roerig, effective February 26, 2026 (SPL set ce3ef5cf-3087-4d92-9d94-9eb8287228db), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

28Ticagrelor generic labelers
31Voriconazole generic labelers
TicagrelorVoriconazole
Labeled forHeart attack and coronary artery disease, Stroke preventionFungal infections
Boxed warningYesNo
Pharmacy cost (NADAC)$0.253 per tablet 90 mg tablet$1.88 per tablet 200 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?